Skip to content
OpenCapital
Get started

West Pharmaceutical Services WST Q1 2026 earnings

Reported April 23, 2026 · Before market open

Revenue$844.9MBeat by $64.6MDiluted EPS$2.13Beat by $0.45
Revenue estimate$780.3M
EPS estimate$1.68

Next report

Jul 23, 2026 (In 1 week)
Revenue estimate$839.7M
EPS estimate$2.08

Financials

Q1 2026

Income statement

See full
Revenue$844.9M+21.0%
Gross profit$296.4M+27.8%
Operating income$177.1M+65.5%
Net income$138.8M+54.6%
EPS (diluted)$1.92+56.1%

Balance sheet

See full
Cash & equivalents$521.4M+29.0%
Total debt$321.0M+4.4%
Total equity$3.0B+11.5%
Total assets$4.1B+13.6%

Cash flow

See full
Operating cash flow$89.9M-30.5%
CapEx$42.7M-40.1%
Free cash flow$47.2M-18.8%

Valuation & ratios

Valuation

as of 07/09/26
See full
Market cap$24.99B+11.6%
Enterprise value$24.79B+11.1%
P/E46×-1.9×
P/S7.8×0.0×

Profitability

See full
Gross margin36.3%+1.7pp
Operating margin20.3%+1.2pp
Net margin16.8%+0.7pp
FCF margin14.2%+3.6pp

Returns & leverage

See full
Return on equity19.1%+1.7pp
Debt / equity0.1×0.0×
Current ratio2.7×-0.1×

Segments

By segment

See full
Proprietary Products$694.3M+23.3%
West Vantage$150.6M—

Versus estimates

Revenue

Q1 2026$844.9MBeat by $64.6M
Q4 2025$805.0MBeat by $10.1MQ3 2025$804.3MBeat by $18.6MQ2 2025$766.2MBeat by $40.1MQ1 2025$698.0MMiss by $15.0MQ4 2024$748.8MBeat by $8.3M

Diluted EPS

Q1 2026$2.13Beat by $0.45
Q4 2025$2.04Beat by $0.21Q3 2025$1.96Beat by $0.28Q2 2025$1.84Beat by $0.33Q1 2025$1.45Beat by $0.23Q4 2024$1.82Beat by $0.11

Ask the moment West Pharmaceutical Services reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did West Pharmaceutical Services report Q1 2026 earnings?
West Pharmaceutical Services (WST) reported Q1 2026 earnings on April 23, 2026 before market open.
What were West Pharmaceutical Services's Q1 2026 revenue and EPS?
West Pharmaceutical Services reported revenue of $844.9M and diluted EPS of $2.13 for Q1 2026.
Did West Pharmaceutical Services beat estimates in Q1 2026?
Revenue beat the consensus estimate of $780.3M by $64.6M. EPS beat the consensus estimate of $1.68 by $0.45.
How did West Pharmaceutical Services's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 21.0% from $698.0M a year earlier and diluted EPS grew 46.9% from $1.45.
Where can I find West Pharmaceutical Services's Q1 2026 SEC filings?
You can read the 8-K earnings release (0000105770-26-000047) and the 10-Q periodic report (0000105770-26-000049) directly on SEC EDGAR. The filing index links above go to sec.gov.